ArticleContemporary oncology (Poznan, Poland)2022

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease.

Hiroaki Satoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.